Management of Clostridioides difficile Infection

C Clarkin, S Quist, R Shamis, AE King, BM Shah - Critical Care Nurse, 2019 - AACN
Clinical Relevance Clostridioides (formerly Clostridium) difficile infection is among the most
identified causes of health care–associated infections in US hospitals and remains a major …

[HTML][HTML] Concurrent and Subsequent Co-Infections of Clostridioides difficile Colitis in the Era of Gut Microbiota and Expanding Treatment Options

M Trunfio, S Scabini, W Rugge, S Bonora, G Di Perri… - Microorganisms, 2022 - mdpi.com
We narratively reviewed the physiopathology, epidemiology, and management of co-
infections in Clostridioides difficile colitis (CDI) by searching the following keywords in …

[HTML][HTML] Systematic review of guidelines for the diagnosis and treatment of Clostridioides difficile infection

T Gu, W Li, LL Yang, SM Yang, Q He, HY He… - Frontiers in Cellular …, 2022 - frontiersin.org
Objective: To systematically assess the current related methodological quality of guidelines
for the diagnosis and treatment of Clostridioides difficile infection (CDI), revealing the …

Emerging alternatives against Clostridioides difficile infection

A Romero-Rodríguez, CM de la Peña… - Anaerobe, 2022 - Elsevier
Clostridioides difficile infection (CDI) is a significant worry within healthcare institutions and
the community. It is one of the leading agents causing severe diarrhea worldwide. Effective …

Changes in treatment of community-onset Clostridioides difficile infection after release of updated guidelines, Atlanta, Georgia, 2018

MW Adelman, D Goodenough, S Sefton, C Mackey… - Anaerobe, 2021 - Elsevier
Updated Clostridioides difficile infection (CDI) guidelines published in 2018 recommend
vancomycin as first-line treatment. Of 833 community-onset CDI cases in metropolitan …

[HTML][HTML] Advances in Clostridioides difficile therapeutics

S Khanna - Expert Review of Anti-infective Therapy, 2021 - Taylor & Francis
Clostridioides difficile is an urgent public health threat by virtue of being the most common
pathogen in hospitals and an increased risk of community-acquired infection [1]. The …

Management and characteristics of patients suffering from Clostridiodes difficile infection in primary care

M Klezovich-Bénard, F Bouchand… - European Journal of …, 2021 - Taylor & Francis
Background Clostridioides difficile infection (CDI) is rising and increases patient healthcare
costs due to extended hospitalisation, tests and medications. Management of CDI in French …

Outcomes associated with recent guideline recommendations removing metronidazole for treatment of non-severe Clostridioides difficile infection: a retrospective …

CA Gentry, DL Campbell, RJ Williams - International Journal of …, 2021 - Elsevier
Abstract Objectives The 2017 Society for Healthcare Epidemiology of America (SHEA) and
Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for Clostridioides …

[PDF][PDF] Vancomycin vs metronidazole use for the treatment of Clostridioides difficile infection in a tertiary care hospital in Saudi Arabia

AF Alhameed, N Saferuddin, T Alturkistani… - Heliyon, 2023 - cell.com
Abstract Background The 2017 Infectious Diseases Society of America (IDSA) Clostridioides
difficile infection (CDI) guidelines recommendation for oral vancomycin as preferred …

[HTML][HTML] Clostridioides difficile infection (CDI): A pan-European multi-center cost and resource utilization study, results from the Combatting Bacterial Resistance in …

SM Wingen-Heimann, K Davies, VF Viprey… - Clinical Microbiology …, 2023 - Elsevier
Objectives Clostridioides difficile infection (CDI) is one of the leading nosocomial infections
worldwide, resulting in a significantly increasing burden on the healthcare systems …